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Edited by Stuart FergusonAbstract Here, we report the ﬁrst investigation of a novel mem-
ber of the LZT (LIV-1 subfamily of ZIP zinc Transporters) sub-
family of zinc inﬂux transporters. LZT subfamily sequences all
contain a unique and highly conserved metalloprotease motif
(HEXPHEXGD) in transmembrane domain V with both histi-
dine residues essential for zinc transport by ZIP (Zrt-, Irt-like
Proteins) transporters. We investigate here whether ZIP14
(SLC39A14), lacking the initial histidine in this motif, is still
able to transport zinc. We demonstrate that this plasma mem-
brane located glycosylated protein functions as a zinc inﬂux
transporter in a temperature-dependant manner.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Zinc is essential to cells, a co-factor for more than 300 en-
zymes [1] and involved in many key aspects of normal cell
growth [2]. Intracellular zinc levels are tightly regulated as zinc
deﬁciency [3] and excess [4] can be detrimental to cells. Zinc
transporters control movement of zinc into, out of and within
cells, having a crucial role in maintaining the cellular balance
between apoptosis and cell growth and disease prevention.
ZIP (Zrt-, Irt-like Proteins) transporters are an important
group of proteins responsible for the control of zinc transport
into the cell cytosol. They can be divided into 4 subfamilies, I,
II, Gufa and LIV-1 [5,6]. The members of the LIV-1 subfamily,
termed LZT (LIV-1 subfamily of ZIP zinc Transporters), are
distinguished by their consensus sequence HEXPHEXGD in
transmembrane (TM) domain V [6]. These LZT sequences,
currently 53 from 12 species [7], now form part of the new sol-
ute carrier family 39 (SLC39A), which includes all the known
ZIP transporters. There are currently 9 human LZT family
members, few of which have been investigated to date. Oestro-
gen-regulated LIV-1 (SLC39A6), implicated in breast cancer,
transports zinc into cells from its position on the plasma mem-Abbreviations: LZT, LIV-1 subfamily of ZIP zinc Transporters; CHO,
Chinese hamster ovary; ZIP, Zrt-, Irt-like Proteins; TM, Transmem-
brane; PNGaseF, peptide N-glycosidase F; TPEN, N,N,N 0,N0-tetrakis-
(2-pyridylmethyl) ethylenediamine
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containing KE4 sequences, is ubiquitously expressed, resides
on internal membranes, particularly the endoplasmic reticu-
lum, and transports zinc into the cytosol from intracellular
stores [7]. BigM103 (SLC39A8, ZIP8) has been shown to reside
in vesicular structures resembling lysosomes and endosomes
and be capable of increasing intracellular zinc [9]. Defects in
the hZIP4 gene (SLC39A4), another LZT family sequence,
have been shown to lead to the zinc deﬁciency disease, acroder-
matitis enteropathica, suggesting that this protein, which is ex-
pressed predominantly in the intestine, is responsible for the
zinc uptake from that tissue [10,11]. Clearly, the LZT proteins
have a comparable function to other ZIP transporters, such as
hZIP1 and hZIP2 [12,13], and are similarly able to control
intracellular zinc levels by transport of zinc into the cytosol.
LIV-1 subfamily of ZIP zinc Transporters sequences contain
similarities to ZIP transporters, including the consensus se-
quence in TM IV which has been shown to be essential for zinc
transport [14], as well as a histidine residue in TM V. This lat-
ter histidine is the initial residue in the HEXPHEXGD motif
of LZT sequences and aligns with the quintessential histidine
in TM V of ZIP transporters [6]. This motif ﬁts the consensus
sequence of the zincin and peptide deformylase groups of
metalloproteases [15–17], where both histidines and the ﬁrst
glutamic acid residue are known to be essential [18].
Therefore a sequence, such as ZIP14 (SLC39A14), with an
EEXPHEXGD motif and lacking the histidine-repeats com-
mon in LZT sequences [19] would be unlikely to transport zinc
if the previous results with ZIP transporters hold fast. Here, we
report the ﬁrst investigation of recombinant human ZIP14
protein and test its ability to transport zinc into cells. We have
engineered recombinant protein to examine location, glycosyl-
ation, abundance and zinc transport ability.2. Materials and methods
2.1. Engineering ZIP14 cDNA
A PCR construct of ZIP14 (gene KIAA0062, clone HA1020, Acces-
sion No. XM_046677) was generated using Biotaq DNA polymerase
from Bioline in conjunction with the following oligonucleotide prim-
ers, where ZIP14 overlap is underlined: 5 0-CCCCACACCA
TGAAGCTGCT GCTGCTGCAC CC-3 0 and 5 0-CCCAATCTGG
ATCTGTCC-3 0. This sequence diﬀers from Q96BB3 [6] with 36 C-ter-
minal residues replaced by 48, which align well with other LZT se-
quences and the mouse homolog (AAH21530) of ZIP14, LZT-Mm4
[6]. The PCR product was ligated with pcDNA3.1/V5-His-TOPO as
described previously [8]. TM deletion mutants were constructed using
3 0 oligonucleotide primers. 5 0-CCCATCCTTC CTTTCATCCTC-3 0
producing a TM7 domain protein (1–458 residues) andblished by Elsevier B.V. All rights reserved.
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main protein (1–304 residues). The production of the LIV-1 and
HKE4 constructs has already been described [7,8].
2.2. Western blotting and deglycosylation
Chinese hamster ovary (CHO) cells (Invitrogen) transfected with
ZIP14 constructs were prepared for Western blot analysis as described
previously [8]. Samples were reduced by addition of 5% b-mercap-
toethanol. To investigate deglycosylation, CHO cell lysates were
incubated with 2 units of endoglycosidase PNGaseF (peptide N-glyco-
sidase F (Boehringer Ingelheim, Bracknell, UK) overnight at 37 C
prior to Western blot in non-reducing conditions.
2.3. FACS analysis and ﬂuorescent microscopy
Chinese hamster ovary cells expressing recombinant proteins were
loaded with Newport Green as described previously [8] and mean ﬂuo-
rescence measured by FACS analysis. The intracellular zinc concentra-
tion was calculated using [Zn2+]i = Kd(F  Fmin)/(Fmax  F), where F,
Fmin and Fmax are the mean ﬂuorescence obtained from the sample, 50
lM zinc chelator TPEN (N,N,N 0,N 0-tetrakis-(2-pyridylmethyl) ethy-
lenediamine) and 100 lM zinc with 10 lM zinc ionophore sodium pyri-
thione, respectively. Cells for ﬂuorescent microscopy were ﬁxed with
4% formaldehyde for 15 min, blocked with 10% normal goat serum,
incubated with anti-V5 antibody (1/2000) for 1 h and Alexa Fluor
488-conjugated anti-mouse antibody (1/1000, Molecular Probes) for
1 h and assembled onto slides using Vectorshield with propidium io-
dide (Vector Laboratories).
2.4. ZIP14 expression in human tissues
A commercially produced Multiple Tissue Expression array
(MTE, Clontech), containing poly A+ RNA from 68 normal human
tissues and 8 cancer cell lines, was hybridised with a ZIP14-speciﬁc
cDNA probe according to the manufacturers instructions.Fig. 1. cDNA sequence of ZIP14: cDNA and amino acid sequence of ZIP14
underlined, histidine-rich region is shaded, signal peptide is in bold italics, L
asterisk indicates the last residue of the mutants TM3 and TM7. Numbers o
cDNA sequence.3. Results
3.1. Computer prediction of ZIP14 secondary structure
Secondary structure prediction of ZIP14 suggests 8 TM do-
mains, a core size of 54 kDa and a cleavable signal peptide be-
tween residues 30 and 31 (Fig. 1). This was achieved using the
combination of computer software described previously [8].
ZIP14 (SLC39A14) belongs to the LZT subgroup of ZIP trans-
porters [6], which have an HEXPHEXGD signature motif.
ZIP14 contains a glutamic acid replacement of the initial histi-
dine in this motif (Fig. 2B, residues 375–384) and, in contrast
to most other family members, contains few histidine residues
throughout the sequence (Fig. 2C). Interestingly, ZIP14 shares
diﬀerences in sequence with another molecule ZIP8, shown by
asterisks in Fig. 2A and B.
3.2. Expression of recombinant ZIP14 proteins
Western blotting of recombinant proteins with the anti-V5
antibody demonstrated a double band (60 kDa) compatible
with the predicted core size of 54 kDa for ZIP14 (WT) and
an additional 5 kDa due to the V5 tag (Fig. 3A, WT). How-
ever, we also observed a band consistent with a trimer and a
high molecular mass band, which increased in non-reducing
conditions (NR). The diﬀerent mutants produced bands of ex-
pected size (Fig. 3A), 57 kDa for TM7 mutant and 42 kDa for
TM3 mutant (predicted 54 and 34 kDa, respectively), allowing
5 kDa for the V5 tag. We conﬁrmed the presence of some or all
of the predicted N-linked glycan chains (residues 77, 87, and(Accession No. XM_046677, SLC39A14). Potential TM domains are
ZT consensus motif (CEXPHEXGD, residues 375–384) is bold and an
n right refer to amino acid sequence and numbers on left refer to the
Fig. 2. Alignment of human LZT sequences across three TM domains: (A) Alignment across TM II with accession numbers in the left-hand column,
followed by LZT family name, gene name, SLC39 name, ZIP name and residue numbers. (B) Alignment across TM IV and V, indicating positions of
ZIP and LZT consensus sequence with dotted arrows. Residues coloured black and grey correspond to identical or complementary residues,
respectively. Asterisks highlight diﬀerences shared by ZIP14 and ZIP8 in otherwise well conserved residues. (C) Schematic of predicted secondary
structure of mutant ZIP14 proteins. TM domains are shaded barrels, numbers in hexagons are histidine residues and total residues are given on the
right side.
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ing the trimer bands, after treatment with PNGaseF (Fig. 3A).
3.3. Cellular location of ZIP14
In order for ZIP14 to act as a zinc inﬂux transporter, it
would have to reside on the plasma membrane. This was dem-
onstrated (Fig. 3B) on coverslips containing non-permeabilised
ZIP14-transfected CHO cells, with particular dense staining in
regions of cell–cell contact. The TM7 and TM3 deletion mu-
tants exhibited the same cellular location (results not shown),
indicating that the loss of TM regions did not alter the cellular
processing.
3.4. Zinc transport analysis
Transfected CHO cells in suspension were loaded with the
cell permeant zinc-speciﬁc ﬂuorescent indicator Newport
Green diacetate [20] and tested for their ability to uptake zinc.
We compared the ZIP14 expressing cells with those expressing
LIV-1, another LZT family member previously shown to
transport zinc [8]. The intracellular zinc concentration
([Zn2+]i) of cells transiently expressing either LIV-1 or ZIP14
increased in response to increasing extracellular zinc concen-tration (Fig. 4A) and was abolished by addition of the zinc
chelator, TPEN (results not shown), conﬁrming the zinc-spec-
iﬁcity of the Newport Green. However, without addition of
extracellular zinc only LIV-1 expressing cells had an [Zn2+]i
greater than the control. The expression level of ZIP14 is con-
siderably greater than that of LIV-1 (Fig. 3B), therefore no
quantitative comparison can be drawn between ZIP14 and
LIV-1 zinc uptake ability. Interestingly, the ZIP14 mutants
lacking 1 or 5 TM domains (TM7 and TM3) were similar to
control cells, suggesting a requirement for all TM domains
for zinc transport. This ability of ZIP14 expressing cells to in-
crease intracellular zinc was temperature-dependant as there
was no evidence of cellular zinc accumulation when these
experiments were repeated at 4 C (results not shown).
3.5. Tissue distribution of ZIP14 expression
The multiple tissue expression array (Fig. 4B) shows ubiqui-
tous expression of ZIP14 with increased expression in Liver
(A9), Pancreas (B9), Foetal liver (D11), Thyroid gland (D9),
Left ventricle (E4), Right atrium (D4), Right ventricle (F4)
and Foetal heart (B11). Of particular interest is the general
expression of ZIP14 in the heart (Lanes 4A–H), intestine
Fig. 3. Western blot and ﬂuorescent microscopy of recombinant ZIP14: (A) Western blot with V5 antibody of CHO cells transiently expressing ZIP14
wild type (WT) and mutant (TM7 and TM3) proteins compared to control CHO cells (CHO) in non-reducing (NR) or reducing (R) conditions.
Treatment with PNGaseF (+) or not () is indicated (PNG). (B) Comparison of ﬂuorescent microscopy of CHO cells stained with propidium iodide
(red) and transfected with LIV-1 or ZIP14 probed with anti-V5 antibody (green).
430 K.M. Taylor et al. / FEBS Letters 579 (2005) 427–432(Lanes 5A–H and 6A–C) and liver (Lane A9) which were neg-
ative for LIV-1 [8] and general low expression in the brain
(Lanes 1–3) which was positive for LIV-1 [8].4. Discussion
Expression of human ZIP14 protein in mammalian cells has
enabled us to show that, ﬁrstly, ZIP14 is closely related to the
previously described ZIP transporters [5,6], known as zinc in-
ﬂux transporters. Secondly, ZIP14 expression in cells increases
the zinc uptake ability in a temperature-dependant manner
from its location on the plasma membrane. These results are
compatible with ZIP14 transporting zinc into cells via a car-
rier-mediated transport process.
This is the ﬁrst demonstration of zinc inﬂux ability of a hu-
man LZT protein containing an altered signature motif,
namely EEXPHEXGD, in place of HEXPHEXGD. This re-
sult agrees with BIGM103, another human LZT family mem-
ber, ZIP8 [9], containing the same motif as ZIP14 in TM V
(Fig. 2B) located on intracellular membranes and transporting
zinc into the cytosol. This result suggests that the histidine res-
idue in TM V, thought to be quintessential for other zinc trans-
porters [14], may not be necessary for zinc transport function
in LZT proteins, although a deﬁnite conclusion is not possible
without now mutating individual residues. Interestingly, the
glutamic acid residue replacing the histidine in TM V (Fig.
2B, residue 382) is a residue capable of co-ordinating zinc[18]. This result conﬁrms the inclusion of ZIP14 in the LZT
subfamily of ZIP transporters by its ability to transport zinc
into cells and justiﬁes the inclusion of other proteins with the
signature motif EEXPHEXGD, such as ZIP8 [9]. These results
show increased intracellular zinc-dependant ﬂuorescence in
cells transfected with ZIP14, which is not present in the
CHO controls. Although this suggests the ability to uptake
zinc across the plasma membrane, especially in the presence
of increased extracellular zinc, we are unable to rule out other
eﬀects such as an ability of these proteins to reorganise the
pool of intracellular zinc available to the Newport Green
dye. The previous judgement by us that ZIP14 did not have
the ability to transport zinc [6] is also consistent with the result
reported here. These previous experiments did not investigate
the eﬀect of increasing extracellular zinc and, as demonstrated
in Fig. 4A, in the absence of extracellular zinc, the ZIP14
expressing cells do not show any increased ﬂuorescence above
controls.
The observed intracellular zinc concentrations were calcu-
lated to be 90 and 350 nM for control and LIV-1 or ZIP14
transfected cells, respectively. The Newport Green dye that
was used for these experiments has a Kd of 1 lM. Therefore,
further detailed investigations of zinc concentrations may be
enhanced by the use of new zinc dyes with lower Kd for zinc.
It is noteworthy that both ZIP14 and ZIP8, apart from the
above variation in TM V, also have a glutamine in place of
a conserved histidine in TM II, and a serine and cysteine in
place of two otherwise conserved glycine residues in TM II
Fig. 4. Zinc transport ability and tissue distribution of recombinant
ZIP14: (A) The variation of intracellular zinc concentration with
extracellular zinc concentration in CHO cells transiently transfected
with no DNA (CHO, hollow squares), LIV-1 (solid squares), or ZIP14
(solid triangles) and mutants (hollow triangles with full line (TM7) and
dotted line (TM3)). Cells were loaded with Newport Green and mean
ﬂuorescence was read by FACS. (B) Autoradiograph of a human
multi-tissue expression array hybridised with a ZIP14 speciﬁc cDNA
probe. Highest levels of expression are observed in Liver (A9),
Pancreas (B9), Foetal liver (D11), Thyroid gland (D9), Left ventricle
(E4), Right atrium (D4), Right ventricle (F4) and Foetal heart (B11),
though it is observed that ZIP14 is ubiquitously expressed. Tissues
represented on the human multi-tissue expression array have been
described previously [8].
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suggestion that the conserved histidine in TM II may act in
concert with the conserved histidine in TM V in transporting
zinc [6].
Interestingly, the ability of ZIP14 to transport zinc suggests
minimal involvement of histidine-rich repeats. Unlike other
human LZT sequences, ZIP14 only contains (HX)4 and
BIGM103 only contains 2(HX)2 [6] in the loop between TM
III and TM IV. This is in keeping with ZIP transporters other
than LZT sequences that only require 3 histidines in a (HX) re-
peat to transport zinc [5,14]. The failure of ZIP14 mutant lack-
ing only TM8 to transport zinc suggests an important role for
all TM domains in this process. Although these mutated pro-
teins located to the plasma membrane, we cannot rule out
alterations in protein processing caused by the absent residues.
The observed plasma membrane location and presence of
glycan chains on ZIP14 are consistent with an extracellular
topology for the N-terminus. The remaining presence of dou-
ble bands after PNGaseF treatment (Fig. 3A) discounts glyco-
sylation variation as the cause. There are no alternative
methionine translation start sites in the N-terminus of
ZIP14, however, translation can rarely initiate at leucine resi-dues of which there are 12 in the initial 200 residues of this se-
quence [21].
The observed tissue expression of ZIP14, in combination
with observations of other LZT proteins [6–11], is consistent
with the tissue speciﬁc expression of these family members.
Recently, LIV-1 has been shown to be essential for the
epithelial–mesenchymal transition (EMT) required in zebraﬁsh
development [22]. Particularly, LIV-1 was the downstream tar-
get of STAT3 and also essential for the nuclear localisation of
Snail, a prerequisite of EMT. The other human LIV-1 family
members, such as ZIP14, should now be investigated to
determine if they also have such a role.
In conclusion, we demonstrate the zinc inﬂux ability of a no-
vel human LZT family member, ZIP14, which lacks a histidine
residue, previously thought to be quintessential, raising the
question of which residues are actually essential for zinc trans-
port. Given the increasing evidence of an important role for
dysregulation of zinc and involvement of LZT family members
in disease states (notably, LIV-1 in breast cancer and hZIP4 in
acrodermatitis enteropathica), it is essential that any relation-
ship of their expression to aberrant cell biology is now
addressed.
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